ISPOR - P20 An Evaluation of Special Considerations in the Assessment and Decision-Making Processes across HTA Agencies for Drugs for Rare Diseases

P20 An Evaluation of Special Considerations in the Assessment and Decision-Making Processes across HTA Agencies for Drugs for Rare Diseases

Abstract

Authors

S. Harricharan M. Musat L. Wiltshire E. Hubscher

Full Text Cite This Article

Back to Volume 26, Supplemental Issue 6S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now